ML20213F452

Requests Addl Info Re 860507 & 0702 Applications for Amend to License 50-23219-01,including Outline of Training Program Used by W Paton to Instruct J Holloway in Use of Lixiscope for Diagnostic Studies

ML20213F452
Person / Time
Site:	03020377
Issue date:	07/30/1986
From:	Thomas R NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V)
To:	Williams F ALASKA NATIVE MEDICAL CENTER, USPHS, ANCHORAGE, AK
Shared Package
ML20213F427	List: ML20213F424 ML20213F429 ML20213F441 ML20213F452 ML20213F482
References
70396, NUDOCS 8611140213
Download: ML20213F452 (1)

See also: IR 05000232/2019001

Text

"g . .

_.. $7  %  % Q' i $ <

JUL 30 ES6

Docket No. : 030-20377

License No.: 50-23219-01

Control No.: 70396 _

,

Department of Health and Human Services

Alaska Native Medical Center

3rd and Gambell Street

Anchorage, Alaska 99501

Attention: Mr. Frank H. Williams

'

Hospital Environmental Control Coordinator

Gentlemen:

This is in reference to your letters dated May 7, 1986 and July 2, 1986 to

amend your byproduct material license. In order to complete our review, we

need the following additional information:

1. You should submit an outline of the training program used by Dr. William

Paton to instruct Dr. Jordan Holloway in the use of the Lixiscope for

diagnostic studies. Also, indicate the number of hours of training

given for. each topic shown on the outline. This training should be at

least 8 hours9.259259e-5 days <br />0.00222 hours <br />1.322751e-5 weeks <br />3.044e-6 months <br /> in duration and must include Items a. , b. , and d. , as

shown on Form NRC-313M, Supplement A, copy enclosed.

Please note that, as discussed in Appendix A to Regulatory Guide 10.8,

training pertinent to an application should have been obtained within 5

years of the date of the application. Training prior to that time

frame is not normally considered unless the individual has had continuous

involvement in nuclear medicine programs.

>

-

2. Similar training and experience documentation must be submitted for each

physician'to be named on the license as an authorized user.

We will continue the review of your amendment request upon receipt of this

information. If we do not receive a reply from you within 30 calendar days

from the date of this letter, we shall assume that you do not wish to pursue

your application. Please reply in duplicate, and refer to Mail Control No.

70396. .

Sincerely,

8611140213 861106

RECS LIC30

50-23219-01 PDR

R. D. Thomas, Chief

nuclear daterials Saic ty bection

0*C' > .................. ..................... ..................... ..................... ..................... ..................... ..RV..f%...

a'1"'* ~

""~> . M* ;%cmnatw- - - -

out> .................. ..................... ..................... ..................... ..................... .................... .. 7. -./2.7/.8.

. . 6. . .... .

IRC F3.~.M 3tJ ttoisOI NRCM o240 OFFICIAL RECORD COPY W u.s.'oro 29 3-40o.24:

. _ . . . . . ...._..<m.%.- .

. . . . 1... ,- . . . . _ . . . _ . . .. _ _ .. .. _ _ m .. m. .e .me u=-- y

_ _ -